Drugmakers uninterested in Trump's order to split up MMR vaccine
First publishedAug 17, 17:00 UTC
Last updatedAug 18, 16:57 UTC · 1m ago
1 outlet
The Hill
1 outlets over time — hover a bar for its window & outletslast updated
Answer
President Trump's executive order recommending that the measles, mumps and rubella (MMR) vaccine be split up across three different appointments is drawing poor reception from the pharmaceutical industry as drugmakers and trade groups say there's no scientific reasoning to follow the directive. The administration did not provide any new scientific data to support splitting up...
Reported by 1 outlet — The Hill. See all sources ↓
Read the full report at The Hill ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
In brief
- What's the story?
- President Trump's executive order recommending that the measles, mumps and rubella (MMR) vaccine be split up across three different appointments is drawing poor reception from the pharmaceutical industry as drugmakers and trade groups say there's no scientific reasoning to follow the directive. The administration did not provide any new scientific data to support splitting up...
- How widely is it covered?
- 1 outlet, average source rating 7.0/10.
- When was it last updated?
- 1m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Drugmakers uninterested in Trump's order to split up MMR vaccine
Sources1TypeCoverage
Sources (1)
Avg source rating 7.0/10Processing cluster
A1A2A3B1B2B3